Following its binding to p25 as opposed to p35, Cdk5 activity becomes deregulated in several neurological disorders, such as AD, PD and Huntington’s disease, eventually leading to neurotoxicity10,11. This evidence concerns the gene CDK5 and Alzheimer disease.